approval · primary record
DENOSUMAB-ADET
FDA · BLA · 2026-09-25
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-09-25 |
| Brand | DEGEVMA |
| Sponsor | TEVA PHARMACEUTICALS, INC. |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:39:32.438Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DENOSUMAB-ADET:2026-09-25
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Denosumab-Adet · compound